Merit Medical Systems Showcases WRAPSODY™ Study and Financials
Company Announcements

Merit Medical Systems Showcases WRAPSODY™ Study and Financials

Merit Medical Systems (MMSI) has provided an update.

Merit recently announced the presentation of six-month outcomes from its pivotal WRAPSODY™ study, set to be discussed at two medical meetings, alongside its quarterly financial results. They plan to host a conference call with a live webcast to delve into these results. While referencing non-GAAP financial information, they note the unpredictable nature of certain expenses prevents them from providing detailed GAAP financial guidance, emphasizing the potential material impact of these uncertainties on future results.

See more insights into MMSI stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyMerit Medical announces findings from WRAPSODY WAVE trial
GlobeNewswireMerit Medical’s WRAPSODY WAVE Trial Demonstrates Superior Patency versus Standard of Care in AV Fistula Patients
TheFlyMerit Medical price target raised to $103 from $92 at BofA
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Go Ad-Free with Our App